Literature DB >> 15671130

Treatment of depression: time to consider folic acid and vitamin B12.

Alec Coppen1, Christina Bolander-Gouaille.   

Abstract

We review the findings in major depression of a low plasma and particularly red cell folate, but also of low vitamin B12 status. Both low folate and low vitamin B12 status have been found in studies of depressive patients, and an association between depression and low levels of the two vitamins is found in studies of the general population. Low plasma or serum folate has also been found in patients with recurrent mood disorders treated by lithium. A link between depression and low folate has similarly been found in patients with alcoholism. It is interesting to note that Hong Kong and Taiwan populations with traditional Chinese diets (rich in folate), including patients with major depression, have high serum folate concentrations. However, these countries have very low life time rates of major depression. Low folate levels are furthermore linked to a poor response to antidepressants, and treatment with folic acid is shown to improve response to antidepressants. A recent study also suggests that high vitamin B12 status may be associated with better treatment outcome. Folate and vitamin B12 are major determinants of one-carbon metabolism, in which S-adenosylmethionine (SAM) is formed. SAM donates methyl groups that are crucial for neurological function. Increased plasma homocysteine is a functional marker of both folate and vitamin B12 deficiency. Increased homocysteine levels are found in depressive patients. In a large population study from Norway increased plasma homocysteine was associated with increased risk of depression but not anxiety. There is now substantial evidence of a common decrease in serum/red blood cell folate, serum vitamin B12 and an increase in plasma homocysteine in depression. Furthermore, the MTHFR C677T polymorphism that impairs the homocysteine metabolism is shown to be overrepresented among depressive patients, which strengthens the association. On the basis of current data, we suggest that oral doses of both folic acid (800 microg daily) and vitamin B12 (1 mg daily) should be tried to improve treatment outcome in depression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15671130     DOI: 10.1177/0269881105048899

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  71 in total

Review 1.  Nutrition and neurodevelopment in children: focus on NUTRIMENTHE project.

Authors:  Tania Anjos; Signe Altmäe; Pauline Emmett; Henning Tiemeier; Ricardo Closa-Monasterolo; Verónica Luque; Sheila Wiseman; Miguel Pérez-García; Eva Lattka; Hans Demmelmair; Bernadette Egan; Niels Straub; Hania Szajewska; Jayne Evans; Claire Horton; Tomas Paus; Elizabeth Isaacs; Jan Willem van Klinken; Berthold Koletzko; Cristina Campoy
Journal:  Eur J Nutr       Date:  2013-07-25       Impact factor: 5.614

Review 2.  Biomarkers of Nutrition for Development (BOND): Vitamin B-12 Review.

Authors:  Lindsay H Allen; Joshua W Miller; Lisette de Groot; Irwin H Rosenberg; A David Smith; Helga Refsum; Daniel J Raiten
Journal:  J Nutr       Date:  2018-12-01       Impact factor: 4.798

3.  Vitamin B12, homocysteine and depressive symptoms: a longitudinal study among older adults.

Authors:  L E M Elstgeest; I A Brouwer; B Wj H Penninx; N M van Schoor; M Visser
Journal:  Eur J Clin Nutr       Date:  2017-02-01       Impact factor: 4.016

Review 4.  What micronutrient deficiencies should be considered in distinct neurological disorders?

Authors:  Pinckney J Maxwell; Stephanie C Montgomery; Rodrigo Cavallazzi; Robert G Martindale
Journal:  Curr Gastroenterol Rep       Date:  2013-07

5.  Vitamin beef.

Authors:  Edward Leyton
Journal:  Can Fam Physician       Date:  2008-06       Impact factor: 3.275

6.  Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamine.

Authors:  N B Lundin; M J Niciu; D A Luckenbaugh; D F Ionescu; E M Richards; J L Vande Voort; N E Brutsche; R Machado-Vieira; C A Zarate
Journal:  Pharmacopsychiatry       Date:  2014-06-23       Impact factor: 5.788

Review 7.  The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors.

Authors:  Jing Du; Ming Zhu; Hongkun Bao; Bai Li; Yilong Dong; Chunjie Xiao; Grace Y Zhang; Ioline Henter; Matthew Rudorfer; Benedetto Vitiello
Journal:  Crit Rev Food Sci Nutr       Date:  2016-11-17       Impact factor: 11.176

8.  Folic Acid Protects Against Glutamate-Induced Excitotoxicity in Hippocampal Slices Through a Mechanism that Implicates Inhibition of GSK-3β and iNOS.

Authors:  Josiane Budni; Simone Molz; Tharine Dal-Cim; Maria Dolores Martín-de-Saavedra; Javier Egea; Manuela G Lopéz; Carla Ines Tasca; Ana Lúcia Severo Rodrigues
Journal:  Mol Neurobiol       Date:  2017-02-10       Impact factor: 5.590

9.  Efficacy of folic acid as an adjunct to lithium therapy on manic-like behaviors, oxidative stress and inflammatory parameters in an animal model of mania.

Authors:  Samira Menegas; Gustavo C Dal-Pont; José H Cararo; Roger B Varela; Jorge M Aguiar-Geraldo; Taise Possamai-Della; Monica L Andersen; João Quevedo; Samira S Valvassori
Journal:  Metab Brain Dis       Date:  2019-12-15       Impact factor: 3.584

10.  Vitamin B12 status in patients of Turkish and Dutch descent with depression: a comparative cross-sectional study.

Authors:  Yener Güzelcan; Peter van Loon
Journal:  Ann Gen Psychiatry       Date:  2009-08-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.